How many insider declarations has Kroeger Christopher A. filed?

Kroeger Christopher A. has filed 4 public insider declarations with SEC (Form 4).

What is Kroeger Christopher A.'s role?

Kroeger Christopher A.'s reported role is not specified by the regulator across the filings.

Which companies does Kroeger Christopher A. report trades for?

Kroeger Christopher A. reports trades for MapLight Therapeutics, Inc..

What is Kroeger Christopher A.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 442k€.

← Executives ★ Sign in to follow

KC

Kroeger Christopher A.

CEOM

US·SEC (Form 4)

MapLight Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€441,829

▼ Sales (3 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

3

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the full record of transactions filed by Kroeger Christopher A.. Officer active across 1 company, notably MapLight Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €442k. History available since 27 October 2025. The latest transaction was filed on 16 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Declarations4 total

▼

Kroeger Christopher A.

Chief Executive OfficerExecutives15 Apr 2026MapLight Therapeutics, Inc.

$246,00654SEC ↗

9,135 shares@ US$26.930.015% mcap47.1% of flowVoting Common StockSEC:0001658918-26-000006:0

▼

Kroeger Christopher A.

Chief Executive OfficerExecutives16 Apr 2026MapLight Therapeutics, Inc.

$66,90448SEC ↗

2,477 shares@ US$27.010.0041% mcap12.9% of flowVoting Common StockSEC:0001658918-26-000006:1

▼

Kroeger Christopher A.

Chief Executive OfficerExecutives16 Apr 2026MapLight Therapeutics, Inc.

$208,23753SEC ↗

7,575 shares@ US$27.490.013% mcap40.0% of flowVoting Common StockSEC:0001658918-26-000006:2

◆

Kroeger Christopher A.

Chief Executive OfficerExecutives27 Oct 2025MapLight Therapeutics, Inc.

0SEC ↗

225,693 shares0Voting Common StockSEC:0001658918-25-000008:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

KC

Kroeger Christopher A.

CEOM

US·SEC (Form 4)

MapLight Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€441,829

▼ Sales (3 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

3

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the full record of transactions filed by Kroeger Christopher A.. Officer active across 1 company, notably MapLight Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €442k. History available since 27 October 2025. The latest transaction was filed on 16 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Declarations4 total

▼

Kroeger Christopher A.

Chief Executive OfficerExecutives15 Apr 2026MapLight Therapeutics, Inc.

$246,00654SEC ↗

9,135 shares@ US$26.930.015% mcap47.1% of flowVoting Common StockSEC:0001658918-26-000006:0

▼

Kroeger Christopher A.

Chief Executive OfficerExecutives16 Apr 2026MapLight Therapeutics, Inc.

$66,90448SEC ↗

2,477 shares@ US$27.010.0041% mcap12.9% of flowVoting Common StockSEC:0001658918-26-000006:1

▼